The study cohort used for this study is the same as that used for the development of original Oxford Classification of IgAN. The study may be considered as an important adjunct to the original Oxford Classification of IgAN, which was entirely based on the pathological evaluation of morphological features [2, 3] . It is worth mentioning here that soon after its publication, some investigators raised the point of lack of immunofluorescence (IF) or electron microscopic (EM) findings in the original classification and their correlation, if any, with the morphological and clinical features at the time of diagnosis and the final outcome [4] . In the backdrop of the above facts, the study is certainly welcome addition to the Oxford Classification of IgAN. However, there is one caveat. The subject study is entirely based on careful scrutiny of the original renal biopsy reports and not on the re-examination of the archived frozen renal biopsy material by the IF test. I have the experience of working on one such project nearly 2 years ago at the Pathology Department of Academic Medical Center (AMC), Amsterdam, under the supervision of Prof. Sanderine Florquin and Dr. Joris Roelofs, which involved repeat IF study of the archived frozen tissue of all IgAN cases in AMC Pathology Department files (M. Mubarak, unpublished data). As I have first hand experience of working on this subject, I have a couple of points to make about this study, the clarification of which will be helpful for all the renal pathologists in their routine practice as well as future research projects on this subject. The points are as follows:
(1) As we all know, the interpretation of capillary wall IF positivity is quite subjective and shows marked interobserver variability. It is worth reiterating here that I have not come across a single case of IgAN with the IF findings similar to those shown in Figure 1B of the subject study. On the other hand, the majority of cases showed peripheral capillary positivity of IgA as shown in Figure 1A . Obviously, the question arises of the definition of capillary wall positivity of IgA staining here. For that matter, do the authors recommend using an immunohistochemical approach for determining the accurate capillary wall positivity? [1] is based on review of the original pathology reports and not of the slides. This was necessary, as there was no access to the original diagnostic material which, in almost all cases, was immunofluorescence (IMF) on frozen sections. As a result, the quality of immunohistological data was potentially limited by interobserver variation between the reporting pathologists. In view of this methodological flaw, it is particularly impressive that strong correlations were found between the IMF findings and light microscopical changes. We agree that if immunohistology is to be included in a classification of IgA nephropathy, then the issue of IMF definitions and reproducibility first needs to be addressed. Whilst there are several studies that have assessed interobserver agreement in the interpretation of the histological changes in renal diseases [2] [3] [4] , there are few such studies applied to renal immunohistology. Interobserver concordance in the interpretation of C4d and SV40 T-antigen positivity in renal transplant biopsies has recently been reported [5, 6] . Similar studies applied to glomerular IMF and immunohistochemistry in native renal disease are lacking. Some researchers suggest that image analysis is superior to subjective interpretation of renal IMF. Interestingly, a recent study reported that, in IgA nephropathy, the presence of adverse histological prognostic features correlated with intensity and total optical density of fluorescence measured using image analysis software, but not with semiquantitative scoring [7] .
Electron microscopy (EM) was not included in the Oxford Classification because neither the reports nor the images were available for most biopsies. We agree that further investigation of the ultrastructural changes in IgA nephropathy is required, in particular correlation with light microscopy and clinical outcome. The future inclusion of ultrastructural features in the Oxford Classification will depend on evidence that EM provides added clinical value. Such evidence is lacking at present, reflected in the limited use of EM in many centres.
